Technology

Filter by Region, Sector, or Focus
Esser will work with scientists to accelerate the development of new medicines and treatments for illnesses like cancer and Alzheimer's.
Esser will work with scientists to accelerate the development of new medicines and treatments for illnesses like cancer and Alzheimer's.
One of Esser's responsibilities will be to foster an "ecosystem of innovation" that will attract biotechnology and pharmaceutical companies to Central Virginia and the greater Commonwealth.
One of Esser's responsibilities will be to foster an "ecosystem of innovation" that will attract biotechnology and pharmaceutical companies to Central Virginia and the greater Commonwealth.
A big, bold vision for a high-impact, future-ready regional economy is in development. The project is supported by a broad coalition of stakeholders, including local government & economic development, higher education & research institutions…
A big, bold vision for a high-impact, future-ready regional economy is in development. The project is supported by a broad coalition of stakeholders, including local government & economic development, higher education & research institutions…
UVA-affiliated startup BrightSpec launched the world's first commercial Molecular Rotational Resonance (MRR) instruments in 50 years. The team received a PittCon Today Excellence Award in recognition of their innovation and the impact of their new…
UVA-affiliated startup BrightSpec launched the world's first commercial Molecular Rotational Resonance (MRR) instruments in 50 years. The team received a PittCon Today Excellence Award in recognition of their innovation and the impact of their new…
As part of the new institute, UVA's Biocomplexity Institute (BI) is contributing innovative AI research and solutions that will bolster efforts to detect illicit financial activity and address vulnerabilities within global supply chains.
A statewide biopharma boom is fueled by talent emerging from Virginia's universities, which provide a steady pipeline of specialized labor.
A statewide biopharma boom is fueled by talent emerging from Virginia's universities, which provide a steady pipeline of specialized labor.
The new UVA institute brings more attention to the proximity of Charlottesville to DC for federal government support efforts.